Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02156739
NA

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.

Official title: Radiologic Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-Enhanced MRI

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2014-10-13

Completion Date

2026-06-01

Last Updated

2025-12-22

Healthy Volunteers

No

Interventions

PROCEDURE

Contrast-enhanced Magnetic Resonance Imaging

Undergo contrast-enhanced MRI

DRUG

Gadobutrol

Given IV

DRUG

Gadoxetate Disodium

Given IV

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States